Publications

Impact of Revised CLSI and Current EUCAST Carbapenem (CARB) Breakpoints on Enterobacteriaceae (ENT) Susceptibility (S) Rates: Report from SENTRY Program, Lead author: Jones RN, presented at 12th annual Western Pacific Congress of Chemotherapy and Infectious Diseases, December 2 – 5, 2010, Singapore

View publication